CLINICAL TRIALS PROFILE FOR GLOFIL-125
✉ Email this page to a colleague
All Clinical Trials for GLOFIL-125
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03273413 ↗ | Statin Therapy in Patients With Early Stage ADPKD | Recruiting | University of Colorado, Denver | Phase 4 | 2017-08-31 | This study plans to learn if pravastatin is helpful in slowing down the progression of kidney disease in adults with autosomal dominant polycystic kidney disease (ADPKD). Pravastatin has been approved by the Food and Drug Administration (FDA) for adults for treatment of hyperlipidemia (high cholesterol levels). The investigators are using pravastatin in this study as an investigational drug for treatment of ADPKD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GLOFIL-125
Condition Name
Clinical Trial Locations for GLOFIL-125
Trials by Country
Clinical Trial Progress for GLOFIL-125
Clinical Trial Phase
Clinical Trial Sponsors for GLOFIL-125
Sponsor Name